Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2022
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic ProfileDavine Hofste Op Bruinink, Rowan Kuiper, Mark van Duin, et al.
The Lancet. Oncology|January 14, 2009
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyMonique L Den Boer, Marjon van Slegtenhorst, Renée X De Menezes, et al.
Blood|August 5, 2011
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression patternIris H I M Hollink, Marry M van den Heuvel-Eibrink, Susan T C J M Arentsen-Peters, et al.
Hemasphere|August 21, 2025
Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALLRoger Mulet-Lazaro, Anikó Sijs-Szabó, Remco M Hoogenboezem, et al.
Blood|February 2, 2022
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndromeTim Grob, Adil S A Al Hinai, Mathijs A Sanders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study GroupKim Klein, Gertjan Kaspers, Christine J Harrison, et al.
Cell|April 8, 2014
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemiaStefan Gröschel, Mathijs A Sanders, Remco Hoogenboezem, et al.
Haematologica|July 28, 2011
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemiaBrian V Balgobind, Iris H I M Hollink, Susan T C J M Arentsen-Peters, et al.
Pageof 10